- Home
- FLWS vs FHTX Comparison
FLWS vs FHTX Comparison
Compare FLWS & FHTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FLWS
- FHTX
- Stock Information
- Founded
- FLWS 1976
- FHTX 2015
- Country
- FLWS United States
- FHTX United States
- Employees
- FLWS N/A
- FHTX N/A
- Industry
- FLWS Other Specialty Stores
- FHTX Medicinal Chemicals and Botanical Products
- Sector
- FLWS Consumer Discretionary
- FHTX Health Care
- Exchange
- FLWS Nasdaq
- FHTX Nasdaq
- Market Cap
- FLWS 524.9M
- FHTX 513.7M
- IPO Year
- FLWS 1999
- FHTX 2020
- Fundamental
- Price
- FLWS $7.17
- FHTX $5.14
- Analyst Decision
- FLWS Hold
- FHTX Strong Buy
- Analyst Count
- FLWS 1
- FHTX 5
- Target Price
- FLWS $7.50
- FHTX $13.80
- AVG Volume (30 Days)
- FLWS 365.9K
- FHTX 197.3K
- Earning Date
- FLWS 01-30-2025
- FHTX 11-04-2024
- Dividend Yield
- FLWS N/A
- FHTX N/A
- EPS Growth
- FLWS N/A
- FHTX N/A
- EPS
- FLWS N/A
- FHTX N/A
- Revenue
- FLWS $1,804,461,000.00
- FHTX $25,515,000.00
- Revenue This Year
- FLWS N/A
- FHTX N/A
- Revenue Next Year
- FLWS $3.28
- FHTX $11.54
- P/E Ratio
- FLWS N/A
- FHTX N/A
- Revenue Growth
- FLWS N/A
- FHTX N/A
- 52 Week Low
- FLWS $7.07
- FHTX $2.70
- 52 Week High
- FLWS $11.42
- FHTX $10.25
- Technical
- Relative Strength Index (RSI)
- FLWS 34.79
- FHTX 27.35
- Support Level
- FLWS $7.07
- FHTX $4.69
- Resistance Level
- FLWS $8.41
- FHTX $5.70
- Average True Range (ATR)
- FLWS 0.41
- FHTX 0.61
- MACD
- FLWS -0.10
- FHTX -0.14
- Stochastic Oscillator
- FLWS 7.46
- FHTX 16.24
About FLWS 1-800-FLOWERS.COM Inc.
1-800-Flowers.com Inc is a provider of gifts designed to help customers express, connect, and celebrate. The company's e-commerce business platform features all brands, including 1-800-Flowers.com, 1-800-Baskets.com, Cheryl's Cookies, Harry and David, PersonalizationMall.com, Shari's Berries, FruitBouquets.com, Moose Munch, The Popcorn Factory, Wolferman's Bakery, Stock Yards, and Simply Chocolate. The company's business segments are; Consumer Floral and Gifts, BloomNet, and Gourmet Foods & Gift Baskets. The maximum revenue for the company is generated from its Gourmet Foods & Gift Baskets segment.
About FHTX Foghorn Therapeutics Inc.
Foghorn Therapeutics Inc is engaged in the discovery and development of a new class of medicines targeting genetically determined dependencies within the chromatin regulatory system. Its proprietary Gene Traffic Control platform gives an integrated, mechanistic understanding of how the various components of the chromatin regulatory system interact, allowing it to identify, validate, and potentially drug targets within the system. The company is developing FHD-286, a selective, allosteric ATPase inhibitor, and FHD-609, a protein degrader, to treat hematologic cancers and solid tumors.